Erb, M. Kelley http://orcid.org/0000-0002-6011-5702
Karlin, Daniel R.
Ho, Bryan K.
Thomas, Kevin C.
Parisi, Federico
Vergara-Diaz, Gloria P.
Daneault, Jean-Francois
Wacnik, Paul W.
Zhang, Hao
Kangarloo, Tairmae
Demanuele, Charmaine
Brooks, Chris R.
Detheridge, Craig N.
Shaafi Kabiri, Nina http://orcid.org/0000-0001-8951-2237
Bhangu, Jaspreet S.
Bonato, Paolo
Funding for this research was provided by:
Pfizer, Inc.
Article History
Received: 10 June 2019
Accepted: 5 December 2019
First Online: 17 January 2020
Competing interests
: M.K.E, D.R.K., P.W.W., H.Z., T.K., and C.D. are currently, or were at the time of study execution or authorship, paid employees of Pfizer. J.F.D is currently a shareholder of NeuroMotrix and Medapplets. P.B. has received grant support from the American Heart Association, the Department of Defense, the Michael J Fox Foundation, the National Institutes of Health (NIH), the National Science Foundation (NSF), and the Peabody Foundation including sub-awards on NIH and NSF SBIR grants from Barrett Technology (Newton, MA), BioSensics (Watertown, MA) and Veristride (Salt Lake City, UT). He has also received grant support from Emerge Diagnostics (Carlsbad, CA), MC10 (Lexington MA), Mitsui Chemicals (Tokyo, Japan), Pfizer (New York City, NY), Shimmer Research (Dublin Ireland), and SynPhNe (Singapore). He serves in an advisory role the Michael J Fox Foundation, the NIH-funded Center for Translation of Rehabilitation Engineering Advances and Technology, and the NIH-funded New England Pediatric Device Consortium. He also serves on the Scientific Advisory Boards of Hocoma AG (Zurich, Switzerland), Trexo (Toronto Canada), and ABLE Human Motion (Barcelona, Spain) in an uncompensated role. All other authors declare no competing interests.